Cargando…
Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® story
Insulin replacement therapy is mostly used by patients with type 2 diabetes who become insulin deficient and have failed other therapeutic options. They comprise about a quarter of those with diabetes, endures the majority of the complications and consumes the majority of the resources. Adequate ins...
Autor principal: | Hodish, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894229/ https://www.ncbi.nlm.nih.gov/pubmed/29682315 http://dx.doi.org/10.1186/s40842-018-0056-5 |
Ejemplares similares
-
Challenges in Insulin Therapy for Type 2 Diabetes: Regarding the Article “Expert Opinion: A Call for Basal Insulin Titration in Patients with Type 2 Diabetes in Daily Practice: Southeast European Perspective” by Nicolae Hancu et al.
por: Hodish, Israel
Publicado: (2021) -
STATs: An Old Story, Yet Mesmerizing
por: Abroun, Saeid, et al.
Publicado: (2015) -
When Patients Tell a Story We Have Not Yet Learned to Hear
por: Hibbs, Stephen
Publicado: (2023) -
Screening for type 1 diabetes: are we nearly there yet?
por: Narendran, Parth
Publicado: (2018) -
Stem-cell therapy for hearing loss: are we there yet?()
por: Dufner-Almeida, Luiz Gustavo, et al.
Publicado: (2019)